Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing to voluntarily sign a consent form and agree to take part in the study.
- People who have been confirmed through tissue or cell testing to have extensive-stage small cell lung cancer (a type of lung cancer that has spread beyond one lung).
- People who are 18 years of age or older.
- People who the treating doctor determines are suitable for treatment with Adebrelimab (a study medication).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are pregnant or currently breastfeeding.
- People who are already taking part in another clinical trial where neither they nor the doctors know which treatment is being given.
- People who have any other condition that the treating doctor considers makes them unsuitable for the study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shengxiang Ren, MD., Shanghai Pulmonary Hospital, Shanghai, China
Phone: +86 17621199707
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Safety (The occurrence of ≥3 grade AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.